|
Clinicopathological characteristics
|
N
|
miR-155-3p expression
|
P
|
|---|
|
Low expression
|
High expression
|
|---|
|
(n = 39)
|
(n = 40)
|
|---|
|
Age (years)
| | | |
0.422
|
|
< 10
|
62
|
29
|
33
| |
|
≥ 10
|
17
|
10
|
7
| |
|
Gender
| | | |
0.494
|
|
Male
|
48
|
22
|
26
| |
|
Female
|
31
|
17
|
14
| |
|
Tumor site
| | | |
0.344
|
|
Cerebellar vermis
|
53
|
24
|
29
| |
|
Cerebellar hemisphere
|
26
|
15
|
11
| |
|
Pathological type
| | | |
0.031
|
|
Classic type
|
46
|
28
|
18
| |
|
Anaplastic/large cell type
|
20
|
8
|
12
| |
|
Fibrogenic/nodular type
|
13
|
3
|
10
| |
|
Molecular subtype
| | | |
0.005
|
|
Wnt
|
26
|
18
|
8
| |
|
SHH
|
14
|
9
|
5
| |
|
Non-Wnt/SHH
|
39
|
12
|
27
| |
|
Metastatic status
| | | |
0.261
|
|
M0
|
43
|
24
|
19
| |
|
M1–3
|
36
|
15
|
21
| |
|
Residual tumor size (cm2)
| | | |
0.252
|
|
≤ 1.5
|
64
|
34
|
30
| |
|
> 1.5
|
15
|
5
|
10
| |
